EXOC2
protein-codingexocyst complex component 2, the group of IPT domain containing|Exocyst complex
Gene summary
The protein encoded by this gene is a component of the exocyst complex, a multi-protein complex essential for the polarized targeting of exocytic vesicles to specific docking sites on the plasma membrane. Though best characterized in yeast, the component proteins and the functions of the exocyst complex have been demonstrated to be highly conserved in higher eukaryotes. At least eight components of the exocyst complex, including this protein, are found to interact with the actin cytoskeletal remodeling and vesicle transport machinery. This interaction has been shown to mediate filopodia formation in fibroblasts. This protein has been shown to interact with the Ral subfamily of GTPases and thereby mediate exocytosis by tethering vesicles to the plasma membrane. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]
- SEC5L1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~208.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0859141
Submitter: PanelApp Australia
Inheritance Pattern: Unknown
Disease ID:MONDO:0859141
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: ClinGen
*EXOC2* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2020 (Van Bergen et al., PMID: 32639540). Phenotypic features reported in affected individuals include developmental delay, intellectual disability, dysmorphisms, brain abnormalities, and poor motor skills. Three variants (1 nonsense and 2 missense) have been reported in the literature. One variant in *EXOC2*, reported in 2 homozygous individuals in one consanguineous family, is included in this curation (PMID: 32639540). This gene-disease relationship is also supported by rescue in patient cells and a *Drosophila* model. Defects in protein expression, global vesicle fusion rates, and cargo delivery in patient fibroblasts were restored to wild-type levels upon transduction of wild-type *EXOC2* (PMID: 32639540). Additionally, knockout of *EXOC2* expression in *Drosophila melanogaster* resulted in impairment of neuromuscular junction growth, neurite outgrowth, and vesicle trafficking to the plasma membrane (PMID: 12575951). Of note, an additional proband with compound heterozygous missense variants has been reported (PMID: 32639540). However, there is conflicting experimental functional evidence using patient cells. Out of caution, evidence for this proband and the missense variants has not been scored as additional evidence is needed to further demonstrate a relationship between these missense variants and disease. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 1, 2023 (SOP Version 9).
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EXOC2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018303.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 12 | 3 | 20 | ||
| missense | 1 | 116 | 1 | 118 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 7 | 7 | ||||
| Total | 1 | 0 | 130 | 12 | 4 | 147 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060773.3 | 27 | MANE Select | |
| Ensembl | ENSP00000230449.4 | 27 | MANE Select | |
| Ensembl | ENSP00000406400.1 | 3 | Standard | |
| Ensembl | ENSP00000540933.1 | 27 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| exoc2 | Danio rerio | Structure: orbital region Quality: increased accumulation abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Ras signaling pathway - Homo sapiens (human)
- RalA downstream regulated genes
- Chromosomal and microsatellite instability in colorectal cancer
- Ras Signaling
- Arf6 trafficking events
Biological Process
- exocytosis
- Golgi to plasma membrane transport
- protein transport
- vesicle-mediated transport
- regulation of entry of bacterium into host cell
Molecular Function
- protein binding
- Ral GTPase binding
- protein kinase binding
- protein N-terminus binding
Cellular Component
- exocyst
- cytosol
- plasma membrane
- membrane
- Flemming body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000230449
- Coding exons
- 27
- Length
- 207985
- Individuals with no LoFs
- 125696
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 52
- Defined
- 125748
- p
- 0.000207
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.70 | 393 | 500 | 0.786 | 0.0000269 | 6071 |
| Missense (PolyPhen) | 133 | 199.52 | 0.66659 | 2374 | ||
| Synonymous | -0.228 | 194 | 190 | 1.02 | 0.0000112 | 1709 |
| Loss of Function | 4.12 | 25 | 59.2 | 0.422 | 0.00000306 | 695 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.00033 | 0.00032 | rare |
| European (Non-Finnish) | 0.00027 | 0.00027 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.;
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- LoFtool
- 0.754
- RVIS EVS
- -0.97
- RVIS percentile EVS
- 8.9
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.959
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |